Cellebrite DI Ltd.

Cellebrite DI Ltd.

Technology

NASDAQ:CLBT · NASDAQ Global Select

Market Cap $3.20B Beta 1.17 P/E (TTM) 44.0
$12.84 +0.00%

+$0.00 today

52W Low $11.02High $19.98

Vol 1.18M · Avg 2.39M

EPS (TTM)$0.29
Software - Infrastructure

Income Statement

Follow revenue through to earnings

Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.

Earnings Waterfall

Revenue to Net Income

Key Ratios

EPS$0.29
Gross Margin83.9%
Net Margin14.6%
P/E Ratio60.3
P/S Ratio33.7

Analysis

$496.4M of revenue converted into $71.9M of net income for the selected period. Gross margin is 83.9% and net margin is 14.6%, showing how much revenue survives after costs and taxes. EPS is $0.29, tying the income statement back to per-share earnings.

Income Statement

Annual data · 0 periods

Metric
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Research & Development
Selling, General & Admin
Operating Expenses
Depreciation & Amortization
EBITDA
EBITDA Margin
Operating Income
Operating Margin
Interest Income
Interest Expense
Other Income / Expenses
Income Before Tax
Pre-Tax Margin
Income Tax Expense
Net Income
Net Margin
EPS (Basic)
EPS (Diluted)
Weighted Avg Shares
Weighted Avg Shares (Diluted)

SEC Filings

Recent regulatory filings

No filings found.

How much revenue does CLBT generate?

Cellebrite DI Ltd. (CLBT) reported $475.68M of revenue in fiscal 2025.

Is CLBT profitable?

Cellebrite DI Ltd. (CLBT) reported $78.33M of net income, with a net margin of 16.5%.

Explore More

Continue the stock analysis

Jump to another research area for this company.